{"gene":"RGS4","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1996,"finding":"RGS4 is a GTPase-activating protein (GAP) that accelerates GTP hydrolysis by Gi alpha subunits at least 40-fold in vitro; all Gi subfamily members tested were substrates, but Gs alpha was not.","method":"In vitro GTPase assay with purified recombinant proteins","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic assay with purified proteins, replicated across multiple subsequent studies","pmids":["8756726"],"is_preprint":false},{"year":1996,"finding":"RGS4 stabilizes the transition state for GTP hydrolysis, binding with high affinity to GDP-AlF4--bound forms of Goalpha and Gialpha (transition-state analogues) but with low affinity to GTPgammaS- and GDP-bound forms, indicating a catalytic rather than effector role.","method":"In vitro GTPase assay, transition-state binding experiments with purified recombinant RGS4","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution with purified proteins, replicated by structural work","pmids":["8910288"],"is_preprint":false},{"year":1997,"finding":"Crystal structure of RGS4 core domain bound to Gialpha1-Mg2+-GDP-AlF4- at 2.8 Å resolution reveals that RGS4 binds the three switch regions of Gialpha1 but contributes no catalytic residues directly contacting GDP or AlF4-; it accelerates GTP hydrolysis primarily by stabilizing the switch region conformation, with Asn-128 potentially interacting with the hydrolytic water.","method":"X-ray crystallography (2.8 Å resolution crystal structure)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional implications, landmark study widely replicated","pmids":["9108480"],"is_preprint":false},{"year":1997,"finding":"RGS4 and GAIP act as GAPs for Gq alpha, blocking activation of phospholipase C beta by GTPgammaS-Gq alpha; the blockade of PLC beta results from occlusion of the effector binding site on Galpha, not solely from GAP activity.","method":"In vitro GTPase assay and PLC beta activation assay with purified proteins and plasma membranes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified proteins, two orthogonal functional assays","pmids":["9012799"],"is_preprint":false},{"year":1997,"finding":"The conserved 120-amino acid RGS domain of RGS4 is sufficient for GTPase-accelerating activity toward Gi class substrates (Gialpha1, Goalpha, Gzalpha) in vitro; short deletions within the RGS domain of RGS4 destroyed GAP activity and Gialpha1 binding.","method":"In vitro GTPase assay, surface plasmon resonance binding, deletion mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with in vitro activity assay and SPR binding, multiple orthogonal methods","pmids":["9207071"],"is_preprint":false},{"year":1997,"finding":"RGS4 inhibits Gq/11-mediated activation of MAPK and phosphoinositide synthesis in COS-7 cells; it competes for effector binding on Galphaq as well as acting as a GAP, demonstrated by inhibition even with AlF4--activated recombinant alphaq.","method":"Transient transfection in COS-7 cells, MAPK activation assay, inositol phosphate synthesis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-based functional assays with multiple readouts, replicated by other groups","pmids":["9115254"],"is_preprint":false},{"year":1997,"finding":"Stable expression of RGS4 in mammalian cells attenuates both Gi-mediated inhibition of cAMP synthesis and Gq-mediated activation of phospholipase C beta, confirming in vivo GAP activity consistent with in vitro selectivity.","method":"Stable transfection in mammalian cells, cAMP assay, phospholipase C assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-based loss/gain-of-function, multiple signaling readouts, replicated across labs","pmids":["9177187"],"is_preprint":false},{"year":1998,"finding":"The N-terminal domain (first ~33 amino acids) of RGS4 confers receptor-selective inhibition of Gq-coupled signaling and is required for high-potency GAP activity; deletion of this domain eliminates receptor selectivity and reduces potency ~10,000-fold; in vitro reconstitution confirmed that both the RGS box and N-terminal flanking sequences are required for high potency.","method":"In vitro reconstitution, deletion mutagenesis, Xenopus oocyte and cell-based signaling assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution plus mutagenesis plus functional cell assays, multiple orthogonal methods","pmids":["9856989"],"is_preprint":false},{"year":1998,"finding":"GAP activity of RGS4 requires the additive effects of multiple residues along the RGS4-Galpha interface that stabilize the Galpha transition-state conformation; Asn-128 is not exclusively required for catalysis, showing RGS4 acts by conformational stabilization rather than direct chemistry.","method":"Mutational analysis combined with biochemical GTPase assays and binding measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with in vitro enzymatic assay, corroborated by structural data","pmids":["9430692"],"is_preprint":false},{"year":1998,"finding":"Plasma membrane localization of RGS4 is required for its in vivo function in inhibiting pheromone signaling in yeast; the N-terminal 33 amino acids constitute a plasma membrane anchorage domain sufficient to localize an otherwise soluble protein to the membrane; RGS4 is palmitoylated at Cys-2 and Cys-12, but palmitoylation of these residues is not required for membrane targeting in yeast.","method":"Yeast functional assay, GFP fusion localization, deletion and cysteine mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization experiments with functional consequence in yeast, mutagenesis, multiple orthogonal methods","pmids":["9576926"],"is_preprint":false},{"year":1998,"finding":"RGS4 inhibits group I metabotropic glutamate receptor (mGluR1a, mGluR5a)-mediated activation of calcium-dependent chloride current in Xenopus oocytes and attenuates mGluR5-mediated inhibition of potassium currents in hippocampal CA1 neurons.","method":"Xenopus oocyte electrophysiology with purified RGS4 microinjection; hippocampal neuron patch-clamp","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein microinjection in two independent cellular systems with electrophysiological readouts","pmids":["9437012"],"is_preprint":false},{"year":1998,"finding":"GTPase-deficient Gialpha2 (Q204L) expression recruits cytoplasmic RGS4 to the plasma membrane, and this occurs even with a non-Gialpha-binding RGS4 mutant (L159F), suggesting indirect recruitment through G-protein activation rather than direct RGS4-Galpha binding.","method":"Subcellular fractionation and immunofluorescence in transfected cells; expression of constitutively active Galpha mutant","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, fractionation plus fluorescence, but the indirect recruitment mechanism inferred from the non-binding mutant result","pmids":["9660808"],"is_preprint":false},{"year":1999,"finding":"RGS4 is palmitoylated at a conserved Cys-95 within the RGS domain (autopalmitoylation with palmitoyl-CoA) as well as at Cys-2/Cys-12 at the N-terminus; palmitoylation of Cys-95 inhibits GAP activity 80–100% in solution-based assays but potentiates activity in receptor-G protein proteoliposomes.","method":"[3H]palmitate labeling in Sf9 cells, autopalmitoylation assay in vitro, single-turnover and steady-state GTPase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution plus cell labeling plus mutagenesis, multiple orthogonal methods","pmids":["10608901"],"is_preprint":false},{"year":1999,"finding":"RGS4 inhibits G-protein-mediated signaling in cardiomyocytes: overexpression blocks phenylephrine- and endothelin-1-mediated gene induction (ANF, MLC-2) and myofilament organization; a GAP-defective point mutant (N128A-RGS4) fails to inhibit, establishing that GAP activity is required.","method":"Cardiomyocyte transfection, reporter gene assay, N128A point mutant control","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function with catalytically dead mutant control, cellular functional assay","pmids":["9918533"],"is_preprint":false},{"year":2000,"finding":"RGS4 is an N-end rule substrate: its N-terminal methionine is removed to expose Cys-2, which is arginylated, making N-terminal Arg the degradation signal; converting Cys-2 to Gly, Ala, or Val completely stabilized RGS4 in reticulocyte lysate.","method":"Expression-cloning screen in reticulocyte lysate, radiochemical N-terminal sequencing, mutagenesis, pulse-chase degradation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical identification of degron with mutagenesis confirmation, multiple methods","pmids":["10783390"],"is_preprint":false},{"year":2000,"finding":"NMR solution structure of free RGS4 reveals an induced conformational change upon binding Gialpha1; the Galpha-binding site is larger and more open in free RGS4, with a kink in the helix (K116-Y119) becoming more pronounced upon binding, enabling hydrogen-bonding to Gialpha1 residues.","method":"2D/3D heteronuclear NMR spectroscopy (30 structures calculated with 2871 restraints)","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution NMR structure with comparison to X-ray complex structure","pmids":["10852703"],"is_preprint":false},{"year":2000,"finding":"The N-terminal domain of RGS4 mediates membrane binding through an amphipathic alpha-helix that interacts with anionic phospholipids via hydrophobic and electrostatic interactions; point mutations neutralizing positive charges or substituting polar residues on the hydrophobic face disrupt membrane targeting and biological activity.","method":"Liposome co-sedimentation, circular dichroism spectroscopy of peptide, mutagenesis in yeast functional assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (biophysical, biochemical, in vivo functional) in one study","pmids":["10764749"],"is_preprint":false},{"year":2000,"finding":"RGS4 selectively enhances alpha2A-adrenoreceptor stimulation of GTPase activity of Galpha-o1 and Galpha-i2, but not Galpha-i1 or Galpha-i3; this selectivity resides in the receptor-G protein context; RGS4 increases both Vmax and Km for GTP.","method":"GTPase activity assay using receptor-Galpha fusion proteins transiently expressed in COS-7 cells; enzyme kinetic analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cell-based receptor-Galpha fusion protein assay, single lab, kinetic analysis","pmids":["10807934"],"is_preprint":false},{"year":2000,"finding":"RGS4 binds the COPI subunit beta'-COP through two dilysine motifs, co-fractionates with the COPI complex, inhibits COPI association with Golgi membranes, and impairs vesicular trafficking (aquaporin-1 and alkaline phosphatase secretion) independently of its GAP activity.","method":"Yeast two-hybrid, in vitro binding with purified proteins, co-fractionation by gel filtration, immunofluorescence, trafficking assays in transfected cells","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Y2H, pulldown, co-fractionation, functional assay), single lab","pmids":["10982407"],"is_preprint":false},{"year":2001,"finding":"The RGS domain of RGS4 and its interaction with pertussis toxin-sensitive Galpha subunits mediates voltage-dependent relaxation of G protein-gated inwardly rectifying K+ (KG/Kir3) channels; RGS domain mutations that impair Galpha binding abolish the relaxation effect.","method":"Xenopus oocyte electrophysiology, expression of RGS4 deletion and point mutants","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis combined with electrophysiological functional assay, multiple receptor and channel combinations tested","pmids":["11507164"],"is_preprint":false},{"year":2001,"finding":"Cardiac-specific expression of RGS4 in transgenic mice reduces Galphaq-induced contractile dysfunction and hypertrophic gene induction (PKC-xi membrane translocation, ANF, alpha-skeletal actin mRNA), establishing RGS4 as an in vivo GAP for Galphaq in the heart.","method":"Dual transgenic mouse model (Galphaq-40 × RGS4), echocardiography, gene expression analysis","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with double-transgenic rescue, multiple functional readouts","pmids":["11162127"],"is_preprint":false},{"year":2003,"finding":"GFP-tagged RGS4 expressed in HEK293 cells localizes to cytosol but is selectively recruited to the plasma membrane by co-expression of Galphai2 or M2 muscarinic receptor; G protein mutants with reduced RGS affinity fail to recruit RGS4, indicating the recruitment involves direct binding.","method":"GFP fusion protein localization in HEK293 cells, co-expression with G protein and receptor mutants, GTPase activity assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional controls using binding-deficient mutants, single lab","pmids":["12920194"],"is_preprint":false},{"year":2005,"finding":"RGS4 and RGS5 are in vivo substrates of the N-end rule pathway: ATE1 Arg-transferase mediates arginylation of N-terminal Cys-2 (after methionine excision), targeting them for ubiquitin-dependent proteasomal degradation via UBR1/UBR2 E3 ligases; mutant RGS4 with Cys-2 unable to become N-terminal is long-lived in vivo; hypoxia perturbs this proteolysis.","method":"ATE1-knockout mouse analysis, UBR1/UBR2 knockout cells, in vivo pulse-chase, mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic knockout of pathway components plus mutagenesis in vivo, multiple orthogonal lines of evidence","pmids":["16217033"],"is_preprint":false},{"year":2005,"finding":"PtdIns(3,4,5)P3 and Ca2+/calmodulin competitively bind to the RGS domain of RGS4 at a cluster of positively charged residues on the surface opposite the Galpha interaction site, reciprocally regulating GAP activity; Ca2+/CaM binding relieves PtdIns(3,4,5)P3-mediated inhibition of GAP activity.","method":"Lipid-protein co-sedimentation assay, surface plasmon resonance, mutagenesis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding and enzymatic assays with mutagenesis, multiple orthogonal methods","pmids":["15324308"],"is_preprint":false},{"year":2005,"finding":"RGS4 directly interacts with C-terminal domains of both mu- and delta-opioid receptors and with the third intracellular loop of the delta-opioid receptor via GST pulldown; RGS4 modulates mu-OR signaling and can form stable heterotrimeric complexes with activated Galpha.","method":"GST fusion protein pulldown, co-immunoprecipitation, cell signaling assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — GST pulldown replicated with co-IP, single lab, no mutagenesis of interaction sites","pmids":["16120478"],"is_preprint":false},{"year":2006,"finding":"PKA and PKG phosphorylate RGS4 at Ser-52, inducing its translocation from cytosol to plasma membrane and enhancing its association with Galphaq.GTP and intrinsic GTPase activity; expression of RGS4(S52A) blocks kinase-mediated increases in GTPase activity and inhibition of PI hydrolysis.","method":"In vitro phosphorylation assay, subcellular fractionation, co-immunoprecipitation, GTPase activity assay, PI hydrolysis assay in smooth muscle cells with S52A mutant","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphorylation site identified with site-directed mutagenesis rescue experiment, multiple orthogonal functional readouts","pmids":["16885398"],"is_preprint":false},{"year":2006,"finding":"RGS4 directly associates with multiple GPCR-Kir3 channel complexes (precoupling mode) through both its N-terminal domain and RGS domain, conferring 100-fold greater potency in accelerating G protein-dependent Kir3 channel-gating kinetics compared to the collision-coupling mode of RGS3s.","method":"Co-immunoprecipitation of epitope-tagged proteins in CHO-K1 cells, Xenopus oocyte electrophysiology, deletion/chimeric RGS constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP with functional electrophysiology and domain mapping, multiple receptor combinations","pmids":["16973624"],"is_preprint":false},{"year":2006,"finding":"RGS4 and GABA(B) R1/R2 subunits are within 100 Å of each other in the plasma membrane as measured by FRET (~13% FRET efficiency), consistent with their association in a signaling complex with Galphao and Kir3 channels.","method":"FRET combined with total internal reflection fluorescence microscopy in HEK293 cells","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — FRET in live cells is consistent with proximity/complex but does not establish direct binding; single lab","pmids":["17185339"],"is_preprint":false},{"year":2007,"finding":"The small molecule CCG-4986 inhibits RGS4 by covalently modifying Cys-132 within the RGS domain on the Galpha-interaction face, causing steric hindrance; sensitivity to CCG-4986 requires Cys-132 and can be introduced into RGS8 by substituting the equivalent residue to cysteine.","method":"Surface plasmon resonance, FRET assay, single-turnover GTP hydrolysis, mass spectrometry, site-directed mutagenesis","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry identification of covalent modification site, mutagenesis validation, multiple orthogonal binding and activity assays","pmids":["17660054"],"is_preprint":false},{"year":2008,"finding":"RGS4-null mice show enhanced bradycardic responses to parasympathetic agonists, lower baseline heart rates, and decreased GIRK channel desensitization in sinoatrial node myocytes, establishing that RGS4 regulates sinus rhythm by inhibiting parasympathetic (Gi/o) signaling and IKACh activity.","method":"RGS4 knockout mouse model, in vivo telemetry, retrograde-perfused heart, SAN myocyte patch-clamp","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple in vivo and ex vivo functional readouts, direct electrophysiology","pmids":["18658048"],"is_preprint":false},{"year":2008,"finding":"IL-1beta upregulates RGS4 expression in colonic smooth muscle via the canonical IKK2/IkappaBalpha/NF-kappaB pathway; siRNA knockdown of RGS4 blocks IL-1beta inhibition of initial contraction and PLC-beta activation, establishing RGS4 as an NF-kappaB target gene mediating IL-1beta effects.","method":"siRNA knockdown, reporter luciferase assay, NF-kappaB-DNA binding, IkappaBalpha degradation, kinase-inactive mutant expression, smooth muscle contraction assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown with dominant-negative mutants and functional readouts, multiple pathway validation methods","pmids":["18260825"],"is_preprint":false},{"year":2009,"finding":"RGS4 selectively modulates delta-opioid receptor (DOR) signaling but not mu-opioid receptor signaling in SH-SY5Y cells; co-immunoprecipitation with a stable RGS4 mutant showed interaction with delta-OR but not mu-OR; the C-tail and third intracellular domain of delta-OR are the interaction sites.","method":"Stable shRNA knockdown (~90% reduction), co-immunoprecipitation, receptor chimeras, cAMP assay, MAPK assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — endogenous knockdown with rescue, co-IP with receptor chimeras mapping interaction domains, multiple signaling readouts","pmids":["19416973"],"is_preprint":false},{"year":2010,"finding":"RGS4 is the dominant RGS protein in pancreatic beta-cell MIN6 insulinoma cells; siRNA-mediated knockdown of RGS4 greatly enhances M3 muscarinic receptor-mediated augmentation of glucose-stimulated insulin secretion (GSIS) and calcium release; beta-cell-specific RGS4 deletion increases muscarinic agonist-induced insulin release in vivo.","method":"siRNA knockdown in MIN6 cells, calcium imaging, insulin secretion assay, conditional beta-cell-specific knockout mice, in vivo plasma insulin measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic approaches (siRNA, cell-specific KO), multiple functional readouts, in vivo confirmation","pmids":["20385802"],"is_preprint":false},{"year":2011,"finding":"Opioid agonist exposure leads to ubiquitination and proteasomal/lysosomal degradation of RGS4 protein in SH-SY5Y cells; this is Gi/o-dependent (blocked by pertussis toxin), reduces RGS4 ~60%, and subsequent cross-talk between delta-OR and M3 muscarinic receptor signaling depends on this RGS4 reduction.","method":"Proteasome inhibitors (MG132, lactacystin), polyubiquitination detection, pertussis toxin treatment, signaling assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition of proteasome with ubiquitination detection, functional cross-talk readout, single lab","pmids":["21209077"],"is_preprint":false},{"year":2012,"finding":"RGS4 is identified as a key link between D2/A2A receptor cAMP/PKA signaling and endocannabinoid mobilization in striatal indirect-pathway MSNs; RGS4-null mice exhibit preserved eCB-LTD after dopamine depletion and significantly reduced motor impairment in the 6-OHDA Parkinson's disease model.","method":"RGS4 knockout mice, electrophysiology (LTD measurements), 6-OHDA lesion model, pharmacological dissection","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with electrophysiological LTD measurement and in vivo disease model, pathway placement via epistasis","pmids":["22284188"],"is_preprint":false},{"year":2012,"finding":"Neurabin scaffolds adenosine A1 receptor and RGS4 into a complex; disruption of this complex (neurabin knockout or RGS4 inhibitor) enhances A1R signaling and protects against excitotoxic seizure, demonstrating that neurabin-RGS4 assembly attenuates A1R-mediated neuroprotection.","method":"Co-immunoprecipitation, neurabin-null mice, RGS4 inhibitor administration, kainate seizure model, neuronal death assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP establishing complex, genetic and pharmacological perturbation with multiple functional readouts in vivo","pmids":["22357852"],"is_preprint":false},{"year":2013,"finding":"NO production (from endothelial-derived eNOS) induces proteasomal degradation of RGS4, relieving repression of the Gbeta-gamma/PI3Kgamma/AKT/mTORC1 pathway and stimulating cardiomyocyte growth; cardiac-specific RGS4 transgenic overexpression prevents this hypertrophy, and eNOS knockout blocks it.","method":"PlGF transgenic mice, eNOS knockout mice, cardiac-specific RGS4 transgenic overexpression, NOS inhibitor L-NAME, Western blot for RGS4 and AKT/mTORC1 signaling","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (transgenic overexpression, knockout, conditional), pharmacological validation, in vivo","pmids":["23454748"],"is_preprint":false},{"year":2013,"finding":"Rab5 and Rab11 regulate RGS4 intracellular trafficking: constitutively active Rab5 decreases RGS4 plasma membrane levels and increases endosomal targeting; dominant-negative Rab11 traps RGS4 in endosomes and decreases its function as inhibitor of M1R/Gq signaling; Cys-12 of RGS4 is important for Rab11-mediated recycling to the plasma membrane.","method":"Constitutively active/dominant-negative Rab GTPase expression, co-localization with endosomal markers, functional M1R/Gq signaling assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative/constitutively active mutants with functional readout, single lab, localization and function linked","pmids":["23733193"],"is_preprint":false},{"year":2014,"finding":"RGS4 interacts with the third intracellular loop of PAR1 directly (purified protein binding) and in live cells (BRET), in a Galpha-o-dependent manner (Galphao but not other Galpha promotes PAR1-RGS4 BRET); RGS4 inhibits PAR1/Galpha-mediated MAPK/ERK signaling but not RhoA signaling.","method":"BRET in COS-7 cells, GST pulldown with purified proteins, PAR1 mutants, signaling assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — BRET plus in vitro pulldown with purified proteins, PAR1 Galpha-coupling mutant controls, single lab","pmids":["24743392"],"is_preprint":false},{"year":2015,"finding":"Deletion of RGS4 predisposes mice to atrial fibrillation; RGS4-null atrial cells show increased Ca2+ spark frequency and abnormal Ca2+ release events under basal conditions and after endothelin-1, attributable to enhanced Galphaq/11-IP3 pathway activity.","method":"RGS4 global knockout mice, in vivo atrial burst pacing electrophysiology, confocal Ca2+ spark imaging, multielectrode array","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with in vivo electrophysiology and direct calcium imaging, pathway mechanistically linked","pmids":["26088132"],"is_preprint":false},{"year":2007,"finding":"RGS4 expression is upregulated in colonic smooth muscle by IL-1beta; siRNA knockdown of RGS4 blocks IL-1beta-mediated inhibition of initial contraction and PLC-beta activation, and RGS4 overexpression inhibits PLC-beta activation.","method":"siRNA knockdown in muscle strips and cultured cells, overexpression, contraction assay, PLC-beta activation measurement","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA and overexpression with functional contractility readouts, single lab, mechanism linked to IL-1beta pathway","pmids":["17959727"],"is_preprint":false}],"current_model":"RGS4 is a GAP for Gi/o and Gq family Galpha subunits that stabilizes the transition-state conformation of Galpha switch regions to accelerate GTP hydrolysis; it associates with the plasma membrane through an N-terminal amphipathic alpha-helix that binds anionic phospholipids, and its plasma membrane localization is required for in vivo function; its N-terminal domain also confers receptor-selective inhibition of Gq signaling by enabling high-affinity precoupling to GPCR-channel macromolecular complexes; it is a substrate of the N-end rule proteolytic pathway, degraded via N-terminal Met excision, Cys-2 oxidation, ATE1-mediated arginylation, and UBR1/UBR2-dependent ubiquitination, with this process regulated by hypoxia and NO; it is phosphorylated by PKA and PKG at Ser-52, triggering membrane translocation and enhanced GAP activity; and it plays defined physiological roles in regulating parasympathetic heart rate control, sinoatrial GIRK channel kinetics, pancreatic beta-cell M3R-insulin secretion, striatal endocannabinoid LTD, chronic pain maintenance, and cardiomyocyte hypertrophic signaling, with its intracellular trafficking regulated by Rab5 and Rab11 GTPases."},"narrative":{"mechanistic_narrative":"RGS4 is a GTPase-activating protein (GAP) that negatively regulates G protein-coupled receptor signaling by accelerating GTP hydrolysis on Gi/o- and Gq-family Galpha subunits, thereby terminating signaling at the level of the heterotrimeric G protein [PMID:8756726, PMID:9012799]. It functions catalytically rather than as an effector: it binds with high affinity to the transition-state (GDP-AlF4-) conformation of Galpha and accelerates hydrolysis at least 40-fold by stabilizing the switch-region conformation rather than contributing catalytic residues, as established biochemically and by the crystal structure of the RGS4 core domain bound to Gialpha1 [PMID:8756726, PMID:8910288, PMID:9108480, PMID:9430692]. The conserved ~120-residue RGS domain is sufficient for GAP activity toward Gi-class substrates [PMID:9207071], and against Gq RGS4 additionally occludes the effector-binding surface to block phospholipase C-beta activation [PMID:9012799, PMID:9115254]. The N-terminal domain confers receptor selectivity and high potency: it forms an amphipathic alpha-helix that anchors RGS4 to anionic phospholipids of the plasma membrane—localization required for function in vivo—and enables direct precoupling to GPCR-channel macromolecular complexes, accounting for ~10,000-fold higher potency than the isolated RGS box [PMID:9856989, PMID:9576926, PMID:10764749, PMID:16973624]. RGS4 activity and abundance are tightly regulated: PKA/PKG phosphorylation at Ser-52 drives membrane translocation and enhances GAP activity [PMID:16885398]; PtdIns(3,4,5)P3 and Ca2+/calmodulin reciprocally modulate the RGS domain [PMID:15324308]; and RGS4 is a physiological N-end rule substrate degraded after Met excision, Cys-2 arginylation by ATE1, and UBR1/UBR2-dependent ubiquitination, a route gated by hypoxia and nitric oxide [PMID:10783390, PMID:16217033, PMID:23454748]. Through these mechanisms RGS4 sets the gain of GPCR signaling in defined physiological contexts, including parasympathetic control of sinoatrial rhythm and GIRK/IKACh kinetics [PMID:18658048], atrial Galphaq/IP3 calcium handling [PMID:26088132], cardiomyocyte hypertrophic signaling [PMID:9918533, PMID:11162127, PMID:23454748], pancreatic beta-cell M3R-dependent insulin secretion [PMID:20385802], and striatal indirect-pathway endocannabinoid LTD relevant to Parkinsonian motor deficits [PMID:22284188].","teleology":[{"year":1996,"claim":"Established that RGS4 is an enzyme that terminates G protein signaling by accelerating GTP hydrolysis, defining RGS proteins as GAPs for heterotrimeric Galpha and explaining a key off-switch for GPCR signaling.","evidence":"In vitro GTPase and transition-state binding assays with purified Gi/o alpha subunits","pmids":["8756726","8910288"],"confidence":"High","gaps":["Did not resolve the structural basis of acceleration","Selectivity across Gq vs Gi families not yet defined in vivo"]},{"year":1997,"claim":"Resolved how RGS4 accelerates hydrolysis—by conformationally stabilizing the three Galpha switch regions rather than supplying catalytic residues—and extended substrate range to Gq with effector-site occlusion as an added inhibitory mechanism.","evidence":"2.8 A crystal structure of RGS4-Gialpha1-GDP-AlF4-, plus PLC-beta and MAPK/phosphoinositide assays for Gq, and RGS-domain deletion mapping","pmids":["9108480","9012799","9115254","9207071","9177187"],"confidence":"High","gaps":["Did not explain receptor selectivity observed in cells","Role of the N-terminal domain beyond the RGS box unaddressed"]},{"year":1998,"claim":"Identified the N-terminal domain as the determinant of receptor-selective, high-potency inhibition and a membrane-anchoring module required for function, separating catalytic chemistry from cellular targeting.","evidence":"In vitro reconstitution, deletion/cysteine mutagenesis, yeast functional and GFP-localization assays, and neuronal/oocyte electrophysiology","pmids":["9856989","9576926","9430692","9437012"],"confidence":"High","gaps":["Biophysical basis of membrane binding not yet defined","Palmitoylation role in mammalian targeting unresolved"]},{"year":2000,"claim":"Defined the membrane-binding mechanism as an amphipathic helix engaging anionic phospholipids and confirmed that this localization is required for biological activity, while NMR revealed an induced-fit conformational change on Galpha binding.","evidence":"Liposome co-sedimentation, circular dichroism, NMR solution structure, and yeast functional mutagenesis","pmids":["10764749","10852703"],"confidence":"High","gaps":["How membrane binding integrates with receptor precoupling not yet shown"]},{"year":1999,"claim":"Showed RGS4 abundance and activity are post-translationally tuned, with autopalmitoylation at Cys-95 and N-terminal cysteines context-dependently modulating GAP activity.","evidence":"[3H]palmitate labeling, in vitro autopalmitoylation, and single-turnover/proteoliposome GTPase assays","pmids":["10608901"],"confidence":"High","gaps":["Physiological enzyme/regulator of palmitoylation not identified","Opposite effects in solution vs proteoliposomes unreconciled"]},{"year":2005,"claim":"Established RGS4 as a bona fide in vivo N-end rule substrate, defining a regulated degradation route (Cys-2 arginylation by ATE1, UBR1/UBR2 ubiquitination) that links RGS4 levels to oxygen and signaling state.","evidence":"ATE1- and UBR1/UBR2-knockout systems, in vivo pulse-chase, and Cys-2 mutagenesis; reciprocal PIP3/Ca-CaM binding by SPR and co-sedimentation","pmids":["16217033","10783390","15324308"],"confidence":"High","gaps":["Upstream signals controlling Cys-2 oxidation in cells incompletely defined","Quantitative contribution of degradation to physiological signaling unclear"]},{"year":2006,"claim":"Defined kinase control and the precoupling mode of action: PKA/PKG phosphorylation at Ser-52 drives membrane translocation and enhanced GAP activity, and direct assembly with GPCR-Kir3 complexes confers ~100-fold potency over collision coupling.","evidence":"Site-directed S52A mutagenesis with fractionation and GTPase/PI assays; co-IP and oocyte electrophysiology with domain-mapped RGS constructs","pmids":["16885398","16973624"],"confidence":"High","gaps":["Stoichiometry and structure of the precoupled complex not resolved","Generality of Ser-52 phosphorylation across tissues not established"]},{"year":2008,"claim":"Demonstrated a physiological role in cardiac rhythm: RGS4 restrains parasympathetic Gi/o signaling at the sinoatrial node, shaping baseline heart rate and GIRK/IKACh kinetics.","evidence":"RGS4-null mice with in vivo telemetry, perfused-heart, and SAN myocyte patch-clamp","pmids":["18658048"],"confidence":"High","gaps":["Receptor specificity at the SAN not fully dissected","Compensation by other RGS proteins not excluded"]},{"year":2012,"claim":"Placed RGS4 in CNS circuit physiology, linking D2/A2A-cAMP/PKA signaling to endocannabinoid mobilization and indirect-pathway LTD, with loss-of-function rescuing motor deficits in a Parkinson's model.","evidence":"RGS4-knockout mice, striatal LTD electrophysiology, and 6-OHDA lesion behavioral analysis; neurabin-A1R scaffolding co-IP and seizure models","pmids":["22284188","22357852"],"confidence":"High","gaps":["Direct Galpha substrate in MSNs not isolated in vivo","Therapeutic window of RGS4 inhibition not defined"]},{"year":2013,"claim":"Connected RGS4 turnover to disease-relevant cardiomyocyte growth, showing NO-induced proteasomal degradation of RGS4 derepresses Gbeta-gamma/PI3Kgamma/AKT/mTORC1 hypertrophic signaling, with trafficking through Rab5/Rab11 endosomal routes setting membrane availability.","evidence":"PlGF transgenic, eNOS-knockout, and cardiac RGS4-overexpression mice with NOS inhibition; Rab5/Rab11 dominant-negative/active mutants with M1R/Gq functional assays","pmids":["23454748","23733193"],"confidence":"High","gaps":["Molecular trigger coupling NO to RGS4 degradation not fully defined","Direct E3 machinery in cardiomyocytes not identified"]},{"year":2015,"claim":"Extended cardiac function to atrial arrhythmia, showing RGS4 loss enhances Galphaq/11-IP3 calcium release and predisposes to atrial fibrillation.","evidence":"RGS4 global-knockout mice with atrial burst pacing and confocal Ca2+ spark imaging","pmids":["26088132"],"confidence":"High","gaps":["Receptor upstream of atrial Gq not specified","Translation to human atrial fibrillation not established"]},{"year":null,"claim":"It remains unresolved how RGS4's multiple regulatory layers—phosphorylation, lipid/Ca2+-CaM modulation, palmitoylation, N-end rule degradation, and Rab-dependent trafficking—are integrated in real time to set receptor-selective signaling gain in a given cell type.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model linking RGS4 modification state to membrane residence and GAP output","Endogenous receptor-RGS4 complex composition in native tissues undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,3,4,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,5,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[16,23]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[26]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[9,16,21,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,21,25]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[37]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,5,6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[14,22]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,34,35]},{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[13,20,30,40]}],"complexes":["GPCR-Kir3 (GIRK) channel precoupling complex","neurabin-A1R-RGS4 complex"],"partners":["GNAI1","GNAO1","GNAQ","ATE1","UBR1","OPRD1","F2R","PPP1R9A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49798","full_name":"Regulator of G-protein signaling 4","aliases":[],"length_aa":205,"mass_kda":23.3,"function":"Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G(z)-alpha is inhibited by phosphorylation of the G-protein. Activity on G(z)-alpha and G(i)-alpha-1 is inhibited by palmitoylation of the G-protein","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P49798/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS4","total_profiled":1310},"omim":[{"mim_id":"611392","title":"2-@AMINOETHANETHIOL DIOXYGENASE; ADO","url":"https://www.omim.org/entry/611392"},{"mim_id":"607120","title":"PHOSPHOLIPASE C, BETA-1; PLCB1","url":"https://www.omim.org/entry/607120"},{"mim_id":"607103","title":"ARGINYLTRANSFERASE 1; ATE1","url":"https://www.omim.org/entry/607103"},{"mim_id":"602516","title":"REGULATOR OF G PROTEIN SIGNALING 4; RGS4","url":"https://www.omim.org/entry/602516"},{"mim_id":"181500","title":"SCHIZOPHRENIA; SCZD","url":"https://www.omim.org/entry/181500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":192.4}],"url":"https://www.proteinatlas.org/search/RGS4"},"hgnc":{"alias_symbol":[],"prev_symbol":["SCZD9"]},"alphafold":{"accession":"P49798","domains":[{"cath_id":"1.10.167.10","chopping":"52-177","consensus_level":"medium","plddt":96.4439,"start":52,"end":177}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49798","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49798-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49798-F1-predicted_aligned_error_v6.png","plddt_mean":78.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS4","jax_strain_url":"https://www.jax.org/strain/search?query=RGS4"},"sequence":{"accession":"P49798","fasta_url":"https://rest.uniprot.org/uniprotkb/P49798.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49798/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49798"}},"corpus_meta":[{"pmid":"9108480","id":"PMC_9108480","title":"Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis.","date":"1997","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9108480","citation_count":704,"is_preprint":false},{"pmid":"8756726","id":"PMC_8756726","title":"GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits.","date":"1996","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8756726","citation_count":677,"is_preprint":false},{"pmid":"11326297","id":"PMC_11326297","title":"Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11326297","citation_count":350,"is_preprint":false},{"pmid":"9012799","id":"PMC_9012799","title":"RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9012799","citation_count":330,"is_preprint":false},{"pmid":"8910288","id":"PMC_8910288","title":"The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8910288","citation_count":295,"is_preprint":false},{"pmid":"12023979","id":"PMC_12023979","title":"Association and linkage analyses of RGS4 polymorphisms in schizophrenia.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12023979","citation_count":269,"is_preprint":false},{"pmid":"16217033","id":"PMC_16217033","title":"RGS4 and RGS5 are in vivo substrates of the N-end rule pathway.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16217033","citation_count":230,"is_preprint":false},{"pmid":"9856989","id":"PMC_9856989","title":"The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9856989","citation_count":212,"is_preprint":false},{"pmid":"9207071","id":"PMC_9207071","title":"The regulators of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity in vitro.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9207071","citation_count":155,"is_preprint":false},{"pmid":"9177187","id":"PMC_9177187","title":"Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9177187","citation_count":149,"is_preprint":false},{"pmid":"22284188","id":"PMC_22284188","title":"RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.","date":"2012","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/22284188","citation_count":148,"is_preprint":false},{"pmid":"10783390","id":"PMC_10783390","title":"RGS4 is arginylated and degraded by the N-end rule pathway in vitro.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10783390","citation_count":137,"is_preprint":false},{"pmid":"9576926","id":"PMC_9576926","title":"Plasma membrane localization is required for RGS4 function in Saccharomyces cerevisiae.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9576926","citation_count":130,"is_preprint":false},{"pmid":"9115254","id":"PMC_9115254","title":"RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115254","citation_count":129,"is_preprint":false},{"pmid":"9437012","id":"PMC_9437012","title":"RGS4 inhibits signaling by group I metabotropic glutamate receptors.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9437012","citation_count":120,"is_preprint":false},{"pmid":"12920194","id":"PMC_12920194","title":"Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12920194","citation_count":114,"is_preprint":false},{"pmid":"9430692","id":"PMC_9430692","title":"Mechanism of RGS4, a GTPase-activating protein for G protein alpha subunits.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430692","citation_count":108,"is_preprint":false},{"pmid":"10764749","id":"PMC_10764749","title":"RGS4 binds to membranes through an amphipathic alpha -helix.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10764749","citation_count":107,"is_preprint":false},{"pmid":"17012620","id":"PMC_17012620","title":"Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17012620","citation_count":105,"is_preprint":false},{"pmid":"18658048","id":"PMC_18658048","title":"RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node.","date":"2008","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18658048","citation_count":103,"is_preprint":false},{"pmid":"14732600","id":"PMC_14732600","title":"Support for RGS4 as a susceptibility gene for schizophrenia.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14732600","citation_count":100,"is_preprint":false},{"pmid":"12176127","id":"PMC_12176127","title":"Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure.","date":"2002","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/12176127","citation_count":96,"is_preprint":false},{"pmid":"17185339","id":"PMC_17185339","title":"Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17185339","citation_count":95,"is_preprint":false},{"pmid":"10608901","id":"PMC_10608901","title":"Palmitoylation of a conserved cysteine in the regulator of G protein signaling (RGS) domain modulates the GTPase-activating activity of RGS4 and RGS10.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608901","citation_count":88,"is_preprint":false},{"pmid":"15870291","id":"PMC_15870291","title":"Generation and characterization of Rgs4 mutant mice.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15870291","citation_count":84,"is_preprint":false},{"pmid":"10942773","id":"PMC_10942773","title":"Rapid kinetics of regulator of G-protein signaling (RGS)-mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 AND RGS7.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10942773","citation_count":83,"is_preprint":false},{"pmid":"15381923","id":"PMC_15381923","title":"Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15381923","citation_count":82,"is_preprint":false},{"pmid":"17301167","id":"PMC_17301167","title":"Allelic variation in RGS4 impacts functional and structural connectivity in the human brain.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17301167","citation_count":82,"is_preprint":false},{"pmid":"16120478","id":"PMC_16120478","title":"Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16120478","citation_count":81,"is_preprint":false},{"pmid":"10233999","id":"PMC_10233999","title":"Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies.","date":"1999","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10233999","citation_count":81,"is_preprint":false},{"pmid":"16565965","id":"PMC_16565965","title":"Regional alterations in RGS4 protein in schizophrenia.","date":"2006","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16565965","citation_count":78,"is_preprint":false},{"pmid":"16860780","id":"PMC_16860780","title":"Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4).","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16860780","citation_count":77,"is_preprint":false},{"pmid":"16631129","id":"PMC_16631129","title":"Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16631129","citation_count":71,"is_preprint":false},{"pmid":"9660808","id":"PMC_9660808","title":"Expression of GTPase-deficient Gialpha2 results in translocation of cytoplasmic RGS4 to the plasma membrane.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9660808","citation_count":70,"is_preprint":false},{"pmid":"9918533","id":"PMC_9918533","title":"RGS4 inhibits G-protein signaling in cardiomyocytes.","date":"1999","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/9918533","citation_count":69,"is_preprint":false},{"pmid":"23454748","id":"PMC_23454748","title":"NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23454748","citation_count":68,"is_preprint":false},{"pmid":"16885398","id":"PMC_16885398","title":"Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is mediated by phosphorylation of RGS4 and GRK2.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16885398","citation_count":68,"is_preprint":false},{"pmid":"20385802","id":"PMC_20385802","title":"RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20385802","citation_count":67,"is_preprint":false},{"pmid":"15055445","id":"PMC_15055445","title":"Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15055445","citation_count":64,"is_preprint":false},{"pmid":"10936173","id":"PMC_10936173","title":"Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT(1B) receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10936173","citation_count":64,"is_preprint":false},{"pmid":"11428836","id":"PMC_11428836","title":"Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure.","date":"2001","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/11428836","citation_count":63,"is_preprint":false},{"pmid":"9515003","id":"PMC_9515003","title":"RGS3 and RGS4 are GTPase activating proteins in the heart.","date":"1998","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/9515003","citation_count":61,"is_preprint":false},{"pmid":"14604980","id":"PMC_14604980","title":"Differentially regulated expression of endogenous RGS4 and RGS7.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14604980","citation_count":61,"is_preprint":false},{"pmid":"15090051","id":"PMC_15090051","title":"Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15090051","citation_count":56,"is_preprint":false},{"pmid":"15548600","id":"PMC_15548600","title":"Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15548600","citation_count":55,"is_preprint":false},{"pmid":"11162127","id":"PMC_11162127","title":"RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11162127","citation_count":55,"is_preprint":false},{"pmid":"17410640","id":"PMC_17410640","title":"The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia.","date":"2007","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/17410640","citation_count":55,"is_preprint":false},{"pmid":"15182322","id":"PMC_15182322","title":"Regional expression of RGS4 mRNA in human brain.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15182322","citation_count":55,"is_preprint":false},{"pmid":"10807934","id":"PMC_10807934","title":"The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adreoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10807934","citation_count":55,"is_preprint":false},{"pmid":"17220354","id":"PMC_17220354","title":"RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17220354","citation_count":54,"is_preprint":false},{"pmid":"14627646","id":"PMC_14627646","title":"Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14627646","citation_count":50,"is_preprint":false},{"pmid":"19416973","id":"PMC_19416973","title":"Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19416973","citation_count":50,"is_preprint":false},{"pmid":"11906535","id":"PMC_11906535","title":"Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain.","date":"2002","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11906535","citation_count":48,"is_preprint":false},{"pmid":"17588543","id":"PMC_17588543","title":"Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17588543","citation_count":46,"is_preprint":false},{"pmid":"17660054","id":"PMC_17660054","title":"The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17660054","citation_count":46,"is_preprint":false},{"pmid":"17959727","id":"PMC_17959727","title":"Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17959727","citation_count":45,"is_preprint":false},{"pmid":"15324308","id":"PMC_15324308","title":"Phosphatidylinositol 3,4,5-trisphosphate and Ca2+/calmodulin competitively bind to the regulators of G-protein-signalling (RGS) domain of RGS4 and reciprocally regulate its action.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15324308","citation_count":45,"is_preprint":false},{"pmid":"16973624","id":"PMC_16973624","title":"RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16973624","citation_count":44,"is_preprint":false},{"pmid":"15660667","id":"PMC_15660667","title":"Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil.","date":"2005","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/15660667","citation_count":43,"is_preprint":false},{"pmid":"25844489","id":"PMC_25844489","title":"Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors.","date":"2015","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25844489","citation_count":41,"is_preprint":false},{"pmid":"17071056","id":"PMC_17071056","title":"Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.","date":"2006","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17071056","citation_count":41,"is_preprint":false},{"pmid":"16905560","id":"PMC_16905560","title":"RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16905560","citation_count":40,"is_preprint":false},{"pmid":"12181442","id":"PMC_12181442","title":"Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i).","date":"2002","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12181442","citation_count":39,"is_preprint":false},{"pmid":"12419501","id":"PMC_12419501","title":"Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum.","date":"2002","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/12419501","citation_count":39,"is_preprint":false},{"pmid":"22562250","id":"PMC_22562250","title":"Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22562250","citation_count":38,"is_preprint":false},{"pmid":"32392739","id":"PMC_32392739","title":"Targeting RGS4 Ablates Glioblastoma Proliferation.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32392739","citation_count":37,"is_preprint":false},{"pmid":"31587286","id":"PMC_31587286","title":"lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31587286","citation_count":37,"is_preprint":false},{"pmid":"9425263","id":"PMC_9425263","title":"Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9425263","citation_count":37,"is_preprint":false},{"pmid":"19041089","id":"PMC_19041089","title":"Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19041089","citation_count":36,"is_preprint":false},{"pmid":"19369446","id":"PMC_19369446","title":"Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19369446","citation_count":36,"is_preprint":false},{"pmid":"10852703","id":"PMC_10852703","title":"NMR structure of free RGS4 reveals an induced conformational change upon binding Galpha.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10852703","citation_count":36,"is_preprint":false},{"pmid":"22357852","id":"PMC_22357852","title":"Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22357852","citation_count":35,"is_preprint":false},{"pmid":"18260825","id":"PMC_18260825","title":"Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18260825","citation_count":35,"is_preprint":false},{"pmid":"18207159","id":"PMC_18207159","title":"RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18207159","citation_count":34,"is_preprint":false},{"pmid":"11755131","id":"PMC_11755131","title":"Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors.","date":"2001","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11755131","citation_count":34,"is_preprint":false},{"pmid":"16082709","id":"PMC_16082709","title":"Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16082709","citation_count":34,"is_preprint":false},{"pmid":"11507164","id":"PMC_11507164","title":"Interaction between the RGS domain of RGS4 with G protein alpha subunits mediates the voltage-dependent relaxation of the G protein-gated potassium channel.","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11507164","citation_count":34,"is_preprint":false},{"pmid":"12422374","id":"PMC_12422374","title":"Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.","date":"2003","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12422374","citation_count":32,"is_preprint":false},{"pmid":"22253691","id":"PMC_22253691","title":"An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22253691","citation_count":31,"is_preprint":false},{"pmid":"18204343","id":"PMC_18204343","title":"RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.","date":"2008","source":"Journal of clinical psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18204343","citation_count":31,"is_preprint":false},{"pmid":"24318880","id":"PMC_24318880","title":"RGS6, but not RGS4, is the dominant regulator of G protein signaling (RGS) modulator of the parasympathetic regulation of mouse heart rate.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24318880","citation_count":31,"is_preprint":false},{"pmid":"16358332","id":"PMC_16358332","title":"Low mRNA levels of RGS4 splice variants in Alzheimer's disease: association between a rare haplotype and decreased mRNA expression.","date":"2006","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16358332","citation_count":31,"is_preprint":false},{"pmid":"23052218","id":"PMC_23052218","title":"Zebrafish rgs4 is essential for motility and axonogenesis mediated by Akt signaling.","date":"2012","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/23052218","citation_count":30,"is_preprint":false},{"pmid":"35781563","id":"PMC_35781563","title":"Bisphenol-A impairs synaptic formation and function by RGS4-mediated regulation of BDNF signaling in the cerebral cortex.","date":"2022","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/35781563","citation_count":30,"is_preprint":false},{"pmid":"16176390","id":"PMC_16176390","title":"Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia.","date":"2005","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/16176390","citation_count":30,"is_preprint":false},{"pmid":"11744024","id":"PMC_11744024","title":"Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS4 and RGS16.","date":"2002","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/11744024","citation_count":29,"is_preprint":false},{"pmid":"23733193","id":"PMC_23733193","title":"Rab family proteins regulate the endosomal trafficking and function of RGS4.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23733193","citation_count":29,"is_preprint":false},{"pmid":"22193724","id":"PMC_22193724","title":"RGS4 overexpression in the rat dorsal striatum modulates mGluR5- and amphetamine-mediated behavior and signaling.","date":"2011","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22193724","citation_count":28,"is_preprint":false},{"pmid":"19153107","id":"PMC_19153107","title":"Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex.","date":"2009","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/19153107","citation_count":28,"is_preprint":false},{"pmid":"15009535","id":"PMC_15009535","title":"Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors.","date":"2004","source":"The journal of peptide research : official journal of the American Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/15009535","citation_count":28,"is_preprint":false},{"pmid":"21209077","id":"PMC_21209077","title":"Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21209077","citation_count":27,"is_preprint":false},{"pmid":"31308097","id":"PMC_31308097","title":"RGS4 Maintains Chronic Pain Symptoms in Rodent Models.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31308097","citation_count":25,"is_preprint":false},{"pmid":"21412219","id":"PMC_21412219","title":"RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.","date":"2011","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/21412219","citation_count":25,"is_preprint":false},{"pmid":"24743392","id":"PMC_24743392","title":"Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743392","citation_count":25,"is_preprint":false},{"pmid":"26088132","id":"PMC_26088132","title":"Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26088132","citation_count":25,"is_preprint":false},{"pmid":"25695583","id":"PMC_25695583","title":"Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.","date":"2015","source":"Anesthesia and analgesia","url":"https://pubmed.ncbi.nlm.nih.gov/25695583","citation_count":25,"is_preprint":false},{"pmid":"10982407","id":"PMC_10982407","title":"RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport.","date":"2000","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10982407","citation_count":24,"is_preprint":false},{"pmid":"16791139","id":"PMC_16791139","title":"Association study of the G-protein signaling 4 (RGS4) and proline dehydrogenase (PRODH) genes with schizophrenia: a meta-analysis.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16791139","citation_count":24,"is_preprint":false},{"pmid":"17707117","id":"PMC_17707117","title":"Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17707117","citation_count":24,"is_preprint":false},{"pmid":"16508931","id":"PMC_16508931","title":"Failure to confirm genetic association between schizophrenia and markers on chromosome 1q23.3 in the region of the gene encoding the regulator of G-protein signaling 4 protein (RGS4).","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16508931","citation_count":24,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53021,"output_tokens":9585,"usd":0.151419,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19681,"output_tokens":4517,"usd":0.105665,"stage2_stop_reason":"end_turn"},"total_usd":0.257084,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS4 is a GTPase-activating protein (GAP) that accelerates GTP hydrolysis by Gi alpha subunits at least 40-fold in vitro; all Gi subfamily members tested were substrates, but Gs alpha was not.\",\n      \"method\": \"In vitro GTPase assay with purified recombinant proteins\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic assay with purified proteins, replicated across multiple subsequent studies\",\n      \"pmids\": [\"8756726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS4 stabilizes the transition state for GTP hydrolysis, binding with high affinity to GDP-AlF4--bound forms of Goalpha and Gialpha (transition-state analogues) but with low affinity to GTPgammaS- and GDP-bound forms, indicating a catalytic rather than effector role.\",\n      \"method\": \"In vitro GTPase assay, transition-state binding experiments with purified recombinant RGS4\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution with purified proteins, replicated by structural work\",\n      \"pmids\": [\"8910288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Crystal structure of RGS4 core domain bound to Gialpha1-Mg2+-GDP-AlF4- at 2.8 Å resolution reveals that RGS4 binds the three switch regions of Gialpha1 but contributes no catalytic residues directly contacting GDP or AlF4-; it accelerates GTP hydrolysis primarily by stabilizing the switch region conformation, with Asn-128 potentially interacting with the hydrolytic water.\",\n      \"method\": \"X-ray crystallography (2.8 Å resolution crystal structure)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional implications, landmark study widely replicated\",\n      \"pmids\": [\"9108480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS4 and GAIP act as GAPs for Gq alpha, blocking activation of phospholipase C beta by GTPgammaS-Gq alpha; the blockade of PLC beta results from occlusion of the effector binding site on Galpha, not solely from GAP activity.\",\n      \"method\": \"In vitro GTPase assay and PLC beta activation assay with purified proteins and plasma membranes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified proteins, two orthogonal functional assays\",\n      \"pmids\": [\"9012799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The conserved 120-amino acid RGS domain of RGS4 is sufficient for GTPase-accelerating activity toward Gi class substrates (Gialpha1, Goalpha, Gzalpha) in vitro; short deletions within the RGS domain of RGS4 destroyed GAP activity and Gialpha1 binding.\",\n      \"method\": \"In vitro GTPase assay, surface plasmon resonance binding, deletion mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with in vitro activity assay and SPR binding, multiple orthogonal methods\",\n      \"pmids\": [\"9207071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS4 inhibits Gq/11-mediated activation of MAPK and phosphoinositide synthesis in COS-7 cells; it competes for effector binding on Galphaq as well as acting as a GAP, demonstrated by inhibition even with AlF4--activated recombinant alphaq.\",\n      \"method\": \"Transient transfection in COS-7 cells, MAPK activation assay, inositol phosphate synthesis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-based functional assays with multiple readouts, replicated by other groups\",\n      \"pmids\": [\"9115254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Stable expression of RGS4 in mammalian cells attenuates both Gi-mediated inhibition of cAMP synthesis and Gq-mediated activation of phospholipase C beta, confirming in vivo GAP activity consistent with in vitro selectivity.\",\n      \"method\": \"Stable transfection in mammalian cells, cAMP assay, phospholipase C assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-based loss/gain-of-function, multiple signaling readouts, replicated across labs\",\n      \"pmids\": [\"9177187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The N-terminal domain (first ~33 amino acids) of RGS4 confers receptor-selective inhibition of Gq-coupled signaling and is required for high-potency GAP activity; deletion of this domain eliminates receptor selectivity and reduces potency ~10,000-fold; in vitro reconstitution confirmed that both the RGS box and N-terminal flanking sequences are required for high potency.\",\n      \"method\": \"In vitro reconstitution, deletion mutagenesis, Xenopus oocyte and cell-based signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution plus mutagenesis plus functional cell assays, multiple orthogonal methods\",\n      \"pmids\": [\"9856989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GAP activity of RGS4 requires the additive effects of multiple residues along the RGS4-Galpha interface that stabilize the Galpha transition-state conformation; Asn-128 is not exclusively required for catalysis, showing RGS4 acts by conformational stabilization rather than direct chemistry.\",\n      \"method\": \"Mutational analysis combined with biochemical GTPase assays and binding measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with in vitro enzymatic assay, corroborated by structural data\",\n      \"pmids\": [\"9430692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Plasma membrane localization of RGS4 is required for its in vivo function in inhibiting pheromone signaling in yeast; the N-terminal 33 amino acids constitute a plasma membrane anchorage domain sufficient to localize an otherwise soluble protein to the membrane; RGS4 is palmitoylated at Cys-2 and Cys-12, but palmitoylation of these residues is not required for membrane targeting in yeast.\",\n      \"method\": \"Yeast functional assay, GFP fusion localization, deletion and cysteine mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization experiments with functional consequence in yeast, mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"9576926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS4 inhibits group I metabotropic glutamate receptor (mGluR1a, mGluR5a)-mediated activation of calcium-dependent chloride current in Xenopus oocytes and attenuates mGluR5-mediated inhibition of potassium currents in hippocampal CA1 neurons.\",\n      \"method\": \"Xenopus oocyte electrophysiology with purified RGS4 microinjection; hippocampal neuron patch-clamp\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein microinjection in two independent cellular systems with electrophysiological readouts\",\n      \"pmids\": [\"9437012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GTPase-deficient Gialpha2 (Q204L) expression recruits cytoplasmic RGS4 to the plasma membrane, and this occurs even with a non-Gialpha-binding RGS4 mutant (L159F), suggesting indirect recruitment through G-protein activation rather than direct RGS4-Galpha binding.\",\n      \"method\": \"Subcellular fractionation and immunofluorescence in transfected cells; expression of constitutively active Galpha mutant\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, fractionation plus fluorescence, but the indirect recruitment mechanism inferred from the non-binding mutant result\",\n      \"pmids\": [\"9660808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS4 is palmitoylated at a conserved Cys-95 within the RGS domain (autopalmitoylation with palmitoyl-CoA) as well as at Cys-2/Cys-12 at the N-terminus; palmitoylation of Cys-95 inhibits GAP activity 80–100% in solution-based assays but potentiates activity in receptor-G protein proteoliposomes.\",\n      \"method\": \"[3H]palmitate labeling in Sf9 cells, autopalmitoylation assay in vitro, single-turnover and steady-state GTPase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution plus cell labeling plus mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"10608901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS4 inhibits G-protein-mediated signaling in cardiomyocytes: overexpression blocks phenylephrine- and endothelin-1-mediated gene induction (ANF, MLC-2) and myofilament organization; a GAP-defective point mutant (N128A-RGS4) fails to inhibit, establishing that GAP activity is required.\",\n      \"method\": \"Cardiomyocyte transfection, reporter gene assay, N128A point mutant control\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function with catalytically dead mutant control, cellular functional assay\",\n      \"pmids\": [\"9918533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS4 is an N-end rule substrate: its N-terminal methionine is removed to expose Cys-2, which is arginylated, making N-terminal Arg the degradation signal; converting Cys-2 to Gly, Ala, or Val completely stabilized RGS4 in reticulocyte lysate.\",\n      \"method\": \"Expression-cloning screen in reticulocyte lysate, radiochemical N-terminal sequencing, mutagenesis, pulse-chase degradation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical identification of degron with mutagenesis confirmation, multiple methods\",\n      \"pmids\": [\"10783390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NMR solution structure of free RGS4 reveals an induced conformational change upon binding Gialpha1; the Galpha-binding site is larger and more open in free RGS4, with a kink in the helix (K116-Y119) becoming more pronounced upon binding, enabling hydrogen-bonding to Gialpha1 residues.\",\n      \"method\": \"2D/3D heteronuclear NMR spectroscopy (30 structures calculated with 2871 restraints)\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution NMR structure with comparison to X-ray complex structure\",\n      \"pmids\": [\"10852703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The N-terminal domain of RGS4 mediates membrane binding through an amphipathic alpha-helix that interacts with anionic phospholipids via hydrophobic and electrostatic interactions; point mutations neutralizing positive charges or substituting polar residues on the hydrophobic face disrupt membrane targeting and biological activity.\",\n      \"method\": \"Liposome co-sedimentation, circular dichroism spectroscopy of peptide, mutagenesis in yeast functional assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (biophysical, biochemical, in vivo functional) in one study\",\n      \"pmids\": [\"10764749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS4 selectively enhances alpha2A-adrenoreceptor stimulation of GTPase activity of Galpha-o1 and Galpha-i2, but not Galpha-i1 or Galpha-i3; this selectivity resides in the receptor-G protein context; RGS4 increases both Vmax and Km for GTP.\",\n      \"method\": \"GTPase activity assay using receptor-Galpha fusion proteins transiently expressed in COS-7 cells; enzyme kinetic analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cell-based receptor-Galpha fusion protein assay, single lab, kinetic analysis\",\n      \"pmids\": [\"10807934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS4 binds the COPI subunit beta'-COP through two dilysine motifs, co-fractionates with the COPI complex, inhibits COPI association with Golgi membranes, and impairs vesicular trafficking (aquaporin-1 and alkaline phosphatase secretion) independently of its GAP activity.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding with purified proteins, co-fractionation by gel filtration, immunofluorescence, trafficking assays in transfected cells\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Y2H, pulldown, co-fractionation, functional assay), single lab\",\n      \"pmids\": [\"10982407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The RGS domain of RGS4 and its interaction with pertussis toxin-sensitive Galpha subunits mediates voltage-dependent relaxation of G protein-gated inwardly rectifying K+ (KG/Kir3) channels; RGS domain mutations that impair Galpha binding abolish the relaxation effect.\",\n      \"method\": \"Xenopus oocyte electrophysiology, expression of RGS4 deletion and point mutants\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis combined with electrophysiological functional assay, multiple receptor and channel combinations tested\",\n      \"pmids\": [\"11507164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cardiac-specific expression of RGS4 in transgenic mice reduces Galphaq-induced contractile dysfunction and hypertrophic gene induction (PKC-xi membrane translocation, ANF, alpha-skeletal actin mRNA), establishing RGS4 as an in vivo GAP for Galphaq in the heart.\",\n      \"method\": \"Dual transgenic mouse model (Galphaq-40 × RGS4), echocardiography, gene expression analysis\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with double-transgenic rescue, multiple functional readouts\",\n      \"pmids\": [\"11162127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GFP-tagged RGS4 expressed in HEK293 cells localizes to cytosol but is selectively recruited to the plasma membrane by co-expression of Galphai2 or M2 muscarinic receptor; G protein mutants with reduced RGS affinity fail to recruit RGS4, indicating the recruitment involves direct binding.\",\n      \"method\": \"GFP fusion protein localization in HEK293 cells, co-expression with G protein and receptor mutants, GTPase activity assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional controls using binding-deficient mutants, single lab\",\n      \"pmids\": [\"12920194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RGS4 and RGS5 are in vivo substrates of the N-end rule pathway: ATE1 Arg-transferase mediates arginylation of N-terminal Cys-2 (after methionine excision), targeting them for ubiquitin-dependent proteasomal degradation via UBR1/UBR2 E3 ligases; mutant RGS4 with Cys-2 unable to become N-terminal is long-lived in vivo; hypoxia perturbs this proteolysis.\",\n      \"method\": \"ATE1-knockout mouse analysis, UBR1/UBR2 knockout cells, in vivo pulse-chase, mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic knockout of pathway components plus mutagenesis in vivo, multiple orthogonal lines of evidence\",\n      \"pmids\": [\"16217033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PtdIns(3,4,5)P3 and Ca2+/calmodulin competitively bind to the RGS domain of RGS4 at a cluster of positively charged residues on the surface opposite the Galpha interaction site, reciprocally regulating GAP activity; Ca2+/CaM binding relieves PtdIns(3,4,5)P3-mediated inhibition of GAP activity.\",\n      \"method\": \"Lipid-protein co-sedimentation assay, surface plasmon resonance, mutagenesis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding and enzymatic assays with mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"15324308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RGS4 directly interacts with C-terminal domains of both mu- and delta-opioid receptors and with the third intracellular loop of the delta-opioid receptor via GST pulldown; RGS4 modulates mu-OR signaling and can form stable heterotrimeric complexes with activated Galpha.\",\n      \"method\": \"GST fusion protein pulldown, co-immunoprecipitation, cell signaling assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — GST pulldown replicated with co-IP, single lab, no mutagenesis of interaction sites\",\n      \"pmids\": [\"16120478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKA and PKG phosphorylate RGS4 at Ser-52, inducing its translocation from cytosol to plasma membrane and enhancing its association with Galphaq.GTP and intrinsic GTPase activity; expression of RGS4(S52A) blocks kinase-mediated increases in GTPase activity and inhibition of PI hydrolysis.\",\n      \"method\": \"In vitro phosphorylation assay, subcellular fractionation, co-immunoprecipitation, GTPase activity assay, PI hydrolysis assay in smooth muscle cells with S52A mutant\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphorylation site identified with site-directed mutagenesis rescue experiment, multiple orthogonal functional readouts\",\n      \"pmids\": [\"16885398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RGS4 directly associates with multiple GPCR-Kir3 channel complexes (precoupling mode) through both its N-terminal domain and RGS domain, conferring 100-fold greater potency in accelerating G protein-dependent Kir3 channel-gating kinetics compared to the collision-coupling mode of RGS3s.\",\n      \"method\": \"Co-immunoprecipitation of epitope-tagged proteins in CHO-K1 cells, Xenopus oocyte electrophysiology, deletion/chimeric RGS constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP with functional electrophysiology and domain mapping, multiple receptor combinations\",\n      \"pmids\": [\"16973624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RGS4 and GABA(B) R1/R2 subunits are within 100 Å of each other in the plasma membrane as measured by FRET (~13% FRET efficiency), consistent with their association in a signaling complex with Galphao and Kir3 channels.\",\n      \"method\": \"FRET combined with total internal reflection fluorescence microscopy in HEK293 cells\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — FRET in live cells is consistent with proximity/complex but does not establish direct binding; single lab\",\n      \"pmids\": [\"17185339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The small molecule CCG-4986 inhibits RGS4 by covalently modifying Cys-132 within the RGS domain on the Galpha-interaction face, causing steric hindrance; sensitivity to CCG-4986 requires Cys-132 and can be introduced into RGS8 by substituting the equivalent residue to cysteine.\",\n      \"method\": \"Surface plasmon resonance, FRET assay, single-turnover GTP hydrolysis, mass spectrometry, site-directed mutagenesis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry identification of covalent modification site, mutagenesis validation, multiple orthogonal binding and activity assays\",\n      \"pmids\": [\"17660054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RGS4-null mice show enhanced bradycardic responses to parasympathetic agonists, lower baseline heart rates, and decreased GIRK channel desensitization in sinoatrial node myocytes, establishing that RGS4 regulates sinus rhythm by inhibiting parasympathetic (Gi/o) signaling and IKACh activity.\",\n      \"method\": \"RGS4 knockout mouse model, in vivo telemetry, retrograde-perfused heart, SAN myocyte patch-clamp\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple in vivo and ex vivo functional readouts, direct electrophysiology\",\n      \"pmids\": [\"18658048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IL-1beta upregulates RGS4 expression in colonic smooth muscle via the canonical IKK2/IkappaBalpha/NF-kappaB pathway; siRNA knockdown of RGS4 blocks IL-1beta inhibition of initial contraction and PLC-beta activation, establishing RGS4 as an NF-kappaB target gene mediating IL-1beta effects.\",\n      \"method\": \"siRNA knockdown, reporter luciferase assay, NF-kappaB-DNA binding, IkappaBalpha degradation, kinase-inactive mutant expression, smooth muscle contraction assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown with dominant-negative mutants and functional readouts, multiple pathway validation methods\",\n      \"pmids\": [\"18260825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RGS4 selectively modulates delta-opioid receptor (DOR) signaling but not mu-opioid receptor signaling in SH-SY5Y cells; co-immunoprecipitation with a stable RGS4 mutant showed interaction with delta-OR but not mu-OR; the C-tail and third intracellular domain of delta-OR are the interaction sites.\",\n      \"method\": \"Stable shRNA knockdown (~90% reduction), co-immunoprecipitation, receptor chimeras, cAMP assay, MAPK assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endogenous knockdown with rescue, co-IP with receptor chimeras mapping interaction domains, multiple signaling readouts\",\n      \"pmids\": [\"19416973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RGS4 is the dominant RGS protein in pancreatic beta-cell MIN6 insulinoma cells; siRNA-mediated knockdown of RGS4 greatly enhances M3 muscarinic receptor-mediated augmentation of glucose-stimulated insulin secretion (GSIS) and calcium release; beta-cell-specific RGS4 deletion increases muscarinic agonist-induced insulin release in vivo.\",\n      \"method\": \"siRNA knockdown in MIN6 cells, calcium imaging, insulin secretion assay, conditional beta-cell-specific knockout mice, in vivo plasma insulin measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic approaches (siRNA, cell-specific KO), multiple functional readouts, in vivo confirmation\",\n      \"pmids\": [\"20385802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Opioid agonist exposure leads to ubiquitination and proteasomal/lysosomal degradation of RGS4 protein in SH-SY5Y cells; this is Gi/o-dependent (blocked by pertussis toxin), reduces RGS4 ~60%, and subsequent cross-talk between delta-OR and M3 muscarinic receptor signaling depends on this RGS4 reduction.\",\n      \"method\": \"Proteasome inhibitors (MG132, lactacystin), polyubiquitination detection, pertussis toxin treatment, signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition of proteasome with ubiquitination detection, functional cross-talk readout, single lab\",\n      \"pmids\": [\"21209077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RGS4 is identified as a key link between D2/A2A receptor cAMP/PKA signaling and endocannabinoid mobilization in striatal indirect-pathway MSNs; RGS4-null mice exhibit preserved eCB-LTD after dopamine depletion and significantly reduced motor impairment in the 6-OHDA Parkinson's disease model.\",\n      \"method\": \"RGS4 knockout mice, electrophysiology (LTD measurements), 6-OHDA lesion model, pharmacological dissection\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with electrophysiological LTD measurement and in vivo disease model, pathway placement via epistasis\",\n      \"pmids\": [\"22284188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Neurabin scaffolds adenosine A1 receptor and RGS4 into a complex; disruption of this complex (neurabin knockout or RGS4 inhibitor) enhances A1R signaling and protects against excitotoxic seizure, demonstrating that neurabin-RGS4 assembly attenuates A1R-mediated neuroprotection.\",\n      \"method\": \"Co-immunoprecipitation, neurabin-null mice, RGS4 inhibitor administration, kainate seizure model, neuronal death assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP establishing complex, genetic and pharmacological perturbation with multiple functional readouts in vivo\",\n      \"pmids\": [\"22357852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NO production (from endothelial-derived eNOS) induces proteasomal degradation of RGS4, relieving repression of the Gbeta-gamma/PI3Kgamma/AKT/mTORC1 pathway and stimulating cardiomyocyte growth; cardiac-specific RGS4 transgenic overexpression prevents this hypertrophy, and eNOS knockout blocks it.\",\n      \"method\": \"PlGF transgenic mice, eNOS knockout mice, cardiac-specific RGS4 transgenic overexpression, NOS inhibitor L-NAME, Western blot for RGS4 and AKT/mTORC1 signaling\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (transgenic overexpression, knockout, conditional), pharmacological validation, in vivo\",\n      \"pmids\": [\"23454748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rab5 and Rab11 regulate RGS4 intracellular trafficking: constitutively active Rab5 decreases RGS4 plasma membrane levels and increases endosomal targeting; dominant-negative Rab11 traps RGS4 in endosomes and decreases its function as inhibitor of M1R/Gq signaling; Cys-12 of RGS4 is important for Rab11-mediated recycling to the plasma membrane.\",\n      \"method\": \"Constitutively active/dominant-negative Rab GTPase expression, co-localization with endosomal markers, functional M1R/Gq signaling assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative/constitutively active mutants with functional readout, single lab, localization and function linked\",\n      \"pmids\": [\"23733193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RGS4 interacts with the third intracellular loop of PAR1 directly (purified protein binding) and in live cells (BRET), in a Galpha-o-dependent manner (Galphao but not other Galpha promotes PAR1-RGS4 BRET); RGS4 inhibits PAR1/Galpha-mediated MAPK/ERK signaling but not RhoA signaling.\",\n      \"method\": \"BRET in COS-7 cells, GST pulldown with purified proteins, PAR1 mutants, signaling assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — BRET plus in vitro pulldown with purified proteins, PAR1 Galpha-coupling mutant controls, single lab\",\n      \"pmids\": [\"24743392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Deletion of RGS4 predisposes mice to atrial fibrillation; RGS4-null atrial cells show increased Ca2+ spark frequency and abnormal Ca2+ release events under basal conditions and after endothelin-1, attributable to enhanced Galphaq/11-IP3 pathway activity.\",\n      \"method\": \"RGS4 global knockout mice, in vivo atrial burst pacing electrophysiology, confocal Ca2+ spark imaging, multielectrode array\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with in vivo electrophysiology and direct calcium imaging, pathway mechanistically linked\",\n      \"pmids\": [\"26088132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS4 expression is upregulated in colonic smooth muscle by IL-1beta; siRNA knockdown of RGS4 blocks IL-1beta-mediated inhibition of initial contraction and PLC-beta activation, and RGS4 overexpression inhibits PLC-beta activation.\",\n      \"method\": \"siRNA knockdown in muscle strips and cultured cells, overexpression, contraction assay, PLC-beta activation measurement\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA and overexpression with functional contractility readouts, single lab, mechanism linked to IL-1beta pathway\",\n      \"pmids\": [\"17959727\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS4 is a GAP for Gi/o and Gq family Galpha subunits that stabilizes the transition-state conformation of Galpha switch regions to accelerate GTP hydrolysis; it associates with the plasma membrane through an N-terminal amphipathic alpha-helix that binds anionic phospholipids, and its plasma membrane localization is required for in vivo function; its N-terminal domain also confers receptor-selective inhibition of Gq signaling by enabling high-affinity precoupling to GPCR-channel macromolecular complexes; it is a substrate of the N-end rule proteolytic pathway, degraded via N-terminal Met excision, Cys-2 oxidation, ATE1-mediated arginylation, and UBR1/UBR2-dependent ubiquitination, with this process regulated by hypoxia and NO; it is phosphorylated by PKA and PKG at Ser-52, triggering membrane translocation and enhanced GAP activity; and it plays defined physiological roles in regulating parasympathetic heart rate control, sinoatrial GIRK channel kinetics, pancreatic beta-cell M3R-insulin secretion, striatal endocannabinoid LTD, chronic pain maintenance, and cardiomyocyte hypertrophic signaling, with its intracellular trafficking regulated by Rab5 and Rab11 GTPases.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RGS4 is a GTPase-activating protein (GAP) that negatively regulates G protein-coupled receptor signaling by accelerating GTP hydrolysis on Gi/o- and Gq-family Galpha subunits, thereby terminating signaling at the level of the heterotrimeric G protein [#0, #3]. It functions catalytically rather than as an effector: it binds with high affinity to the transition-state (GDP-AlF4-) conformation of Galpha and accelerates hydrolysis at least 40-fold by stabilizing the switch-region conformation rather than contributing catalytic residues, as established biochemically and by the crystal structure of the RGS4 core domain bound to Gialpha1 [#0, #1, #2, #8]. The conserved ~120-residue RGS domain is sufficient for GAP activity toward Gi-class substrates [#4], and against Gq RGS4 additionally occludes the effector-binding surface to block phospholipase C-beta activation [#3, #5]. The N-terminal domain confers receptor selectivity and high potency: it forms an amphipathic alpha-helix that anchors RGS4 to anionic phospholipids of the plasma membrane—localization required for function in vivo—and enables direct precoupling to GPCR-channel macromolecular complexes, accounting for ~10,000-fold higher potency than the isolated RGS box [#7, #9, #16, #26]. RGS4 activity and abundance are tightly regulated: PKA/PKG phosphorylation at Ser-52 drives membrane translocation and enhances GAP activity [#25]; PtdIns(3,4,5)P3 and Ca2+/calmodulin reciprocally modulate the RGS domain [#23]; and RGS4 is a physiological N-end rule substrate degraded after Met excision, Cys-2 arginylation by ATE1, and UBR1/UBR2-dependent ubiquitination, a route gated by hypoxia and nitric oxide [#14, #22, #36]. Through these mechanisms RGS4 sets the gain of GPCR signaling in defined physiological contexts, including parasympathetic control of sinoatrial rhythm and GIRK/IKACh kinetics [#29], atrial Galphaq/IP3 calcium handling [#39], cardiomyocyte hypertrophic signaling [#13, #20, #36], pancreatic beta-cell M3R-dependent insulin secretion [#32], and striatal indirect-pathway endocannabinoid LTD relevant to Parkinsonian motor deficits [#34].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that RGS4 is an enzyme that terminates G protein signaling by accelerating GTP hydrolysis, defining RGS proteins as GAPs for heterotrimeric Galpha and explaining a key off-switch for GPCR signaling.\",\n      \"evidence\": \"In vitro GTPase and transition-state binding assays with purified Gi/o alpha subunits\",\n      \"pmids\": [\"8756726\", \"8910288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of acceleration\", \"Selectivity across Gq vs Gi families not yet defined in vivo\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolved how RGS4 accelerates hydrolysis—by conformationally stabilizing the three Galpha switch regions rather than supplying catalytic residues—and extended substrate range to Gq with effector-site occlusion as an added inhibitory mechanism.\",\n      \"evidence\": \"2.8 A crystal structure of RGS4-Gialpha1-GDP-AlF4-, plus PLC-beta and MAPK/phosphoinositide assays for Gq, and RGS-domain deletion mapping\",\n      \"pmids\": [\"9108480\", \"9012799\", \"9115254\", \"9207071\", \"9177187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain receptor selectivity observed in cells\", \"Role of the N-terminal domain beyond the RGS box unaddressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified the N-terminal domain as the determinant of receptor-selective, high-potency inhibition and a membrane-anchoring module required for function, separating catalytic chemistry from cellular targeting.\",\n      \"evidence\": \"In vitro reconstitution, deletion/cysteine mutagenesis, yeast functional and GFP-localization assays, and neuronal/oocyte electrophysiology\",\n      \"pmids\": [\"9856989\", \"9576926\", \"9430692\", \"9437012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biophysical basis of membrane binding not yet defined\", \"Palmitoylation role in mammalian targeting unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the membrane-binding mechanism as an amphipathic helix engaging anionic phospholipids and confirmed that this localization is required for biological activity, while NMR revealed an induced-fit conformational change on Galpha binding.\",\n      \"evidence\": \"Liposome co-sedimentation, circular dichroism, NMR solution structure, and yeast functional mutagenesis\",\n      \"pmids\": [\"10764749\", \"10852703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How membrane binding integrates with receptor precoupling not yet shown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed RGS4 abundance and activity are post-translationally tuned, with autopalmitoylation at Cys-95 and N-terminal cysteines context-dependently modulating GAP activity.\",\n      \"evidence\": \"[3H]palmitate labeling, in vitro autopalmitoylation, and single-turnover/proteoliposome GTPase assays\",\n      \"pmids\": [\"10608901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological enzyme/regulator of palmitoylation not identified\", \"Opposite effects in solution vs proteoliposomes unreconciled\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established RGS4 as a bona fide in vivo N-end rule substrate, defining a regulated degradation route (Cys-2 arginylation by ATE1, UBR1/UBR2 ubiquitination) that links RGS4 levels to oxygen and signaling state.\",\n      \"evidence\": \"ATE1- and UBR1/UBR2-knockout systems, in vivo pulse-chase, and Cys-2 mutagenesis; reciprocal PIP3/Ca-CaM binding by SPR and co-sedimentation\",\n      \"pmids\": [\"16217033\", \"10783390\", \"15324308\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling Cys-2 oxidation in cells incompletely defined\", \"Quantitative contribution of degradation to physiological signaling unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined kinase control and the precoupling mode of action: PKA/PKG phosphorylation at Ser-52 drives membrane translocation and enhanced GAP activity, and direct assembly with GPCR-Kir3 complexes confers ~100-fold potency over collision coupling.\",\n      \"evidence\": \"Site-directed S52A mutagenesis with fractionation and GTPase/PI assays; co-IP and oocyte electrophysiology with domain-mapped RGS constructs\",\n      \"pmids\": [\"16885398\", \"16973624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the precoupled complex not resolved\", \"Generality of Ser-52 phosphorylation across tissues not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated a physiological role in cardiac rhythm: RGS4 restrains parasympathetic Gi/o signaling at the sinoatrial node, shaping baseline heart rate and GIRK/IKACh kinetics.\",\n      \"evidence\": \"RGS4-null mice with in vivo telemetry, perfused-heart, and SAN myocyte patch-clamp\",\n      \"pmids\": [\"18658048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor specificity at the SAN not fully dissected\", \"Compensation by other RGS proteins not excluded\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed RGS4 in CNS circuit physiology, linking D2/A2A-cAMP/PKA signaling to endocannabinoid mobilization and indirect-pathway LTD, with loss-of-function rescuing motor deficits in a Parkinson's model.\",\n      \"evidence\": \"RGS4-knockout mice, striatal LTD electrophysiology, and 6-OHDA lesion behavioral analysis; neurabin-A1R scaffolding co-IP and seizure models\",\n      \"pmids\": [\"22284188\", \"22357852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Galpha substrate in MSNs not isolated in vivo\", \"Therapeutic window of RGS4 inhibition not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected RGS4 turnover to disease-relevant cardiomyocyte growth, showing NO-induced proteasomal degradation of RGS4 derepresses Gbeta-gamma/PI3Kgamma/AKT/mTORC1 hypertrophic signaling, with trafficking through Rab5/Rab11 endosomal routes setting membrane availability.\",\n      \"evidence\": \"PlGF transgenic, eNOS-knockout, and cardiac RGS4-overexpression mice with NOS inhibition; Rab5/Rab11 dominant-negative/active mutants with M1R/Gq functional assays\",\n      \"pmids\": [\"23454748\", \"23733193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trigger coupling NO to RGS4 degradation not fully defined\", \"Direct E3 machinery in cardiomyocytes not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended cardiac function to atrial arrhythmia, showing RGS4 loss enhances Galphaq/11-IP3 calcium release and predisposes to atrial fibrillation.\",\n      \"evidence\": \"RGS4 global-knockout mice with atrial burst pacing and confocal Ca2+ spark imaging\",\n      \"pmids\": [\"26088132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor upstream of atrial Gq not specified\", \"Translation to human atrial fibrillation not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how RGS4's multiple regulatory layers—phosphorylation, lipid/Ca2+-CaM modulation, palmitoylation, N-end rule degradation, and Rab-dependent trafficking—are integrated in real time to set receptor-selective signaling gain in a given cell type.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model linking RGS4 modification state to membrane residence and GAP output\", \"Endogenous receptor-RGS4 complex composition in native tissues undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 3, 4, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 5, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [16, 23]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [9, 16, 21, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 21, 25]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [37]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [14, 22]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 34, 35]},\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [13, 20, 30, 40]}\n    ],\n    \"complexes\": [\n      \"GPCR-Kir3 (GIRK) channel precoupling complex\",\n      \"neurabin-A1R-RGS4 complex\"\n    ],\n    \"partners\": [\n      \"GNAI1\",\n      \"GNAO1\",\n      \"GNAQ\",\n      \"ATE1\",\n      \"UBR1\",\n      \"OPRD1\",\n      \"F2R\",\n      \"PPP1R9A\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}